Total Payments
$4,813
2021 Payments
$136.45
Companies
28
Transactions
312
Medicare Patients
913
Medicare Billing
$73,552
Payment Breakdown by Category
Food & Beverage$4,808 (99.9%)
Education$5.00 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,808 | 311 | 99.9% |
| Education | $5.00 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $573.48 | 33 | $0 (2021) |
| Merck Sharp & Dohme Corporation | $514.05 | 31 | $0 (2020) |
| Novo Nordisk Inc | $502.26 | 55 | $0 (2021) |
| Astellas Pharma US Inc | $474.11 | 26 | $0 (2019) |
| Amgen Inc. | $410.76 | 16 | $0 (2020) |
| Lilly USA, LLC | $253.88 | 25 | $0 (2019) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $224.03 | 15 | $0 (2021) |
| SANOFI-AVENTIS U.S. LLC | $220.51 | 15 | $0 (2021) |
| PFIZER INC. | $207.29 | 20 | $0 (2020) |
| Allergan, Inc. | $203.35 | 19 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2021 | $136.45 | 8 | Boehringer Ingelheim Pharmaceuticals, Inc. ($37.13) |
| 2020 | $228.51 | 15 | Novo Nordisk Inc ($38.64) |
| 2019 | $1,285 | 90 | Novo Nordisk Inc ($239.40) |
| 2018 | $1,196 | 81 | Merck Sharp & Dohme Corporation ($170.31) |
| 2017 | $1,966 | 118 | Astellas Pharma US Inc ($339.98) |
All Payment Transactions
312 individual payment records from CMS Open Payments — Page 1 of 13
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/24/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $15.35 | General |
| Category: NEUROSCIENCE | ||||||
| 11/02/2021 | Boehringer Ingelheim Pharmaceuticals, Inc. | TRADJENTA (Drug), JARDIANCE, GLYXAMBI | Food and Beverage | In-kind items and services | $17.96 | General |
| Category: DIABETES | ||||||
| 10/26/2021 | SANOFI-AVENTIS U.S. LLC | SOLIQUA 100/33 (Biological) | Food and Beverage | In-kind items and services | $13.53 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 09/23/2021 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $17.86 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/21/2021 | SANOFI-AVENTIS U.S. LLC | SOLIQUA 100/33 (Biological) | Food and Beverage | In-kind items and services | $16.49 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 07/13/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $16.78 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 05/25/2021 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $19.31 | General |
| Category: Diabetes | ||||||
| 01/29/2021 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug), GLYXAMBI, SYNJARDY | Food and Beverage | In-kind items and services | $19.17 | General |
| Category: DIABETES | ||||||
| 10/27/2020 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug), GLYXAMBI, SYNJARDY XR | Food and Beverage | In-kind items and services | $21.33 | General |
| Category: DIABETES | ||||||
| 09/17/2020 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), STEGLATRO, STEGLUJAN | Food and Beverage | In-kind items and services | $23.11 | General |
| Category: ENDOCRINOLOGY | ||||||
| 08/24/2020 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $11.95 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 07/22/2020 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.23 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/09/2020 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $11.67 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/08/2020 | Allergan, Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $13.78 | General |
| Category: NEUROSCIENCE | ||||||
| 03/02/2020 | Novo Nordisk Inc | Tresiba (Drug) | Food and Beverage | In-kind items and services | $14.69 | General |
| Category: Diabetes | ||||||
| 02/27/2020 | SANOFI-AVENTIS U.S. LLC | SOLIQUA 100/33 (Biological) | Food and Beverage | In-kind items and services | $14.94 | General |
| Category: Endocrinology | ||||||
| 02/26/2020 | Merck Sharp & Dohme Corporation | PNEUMOVAX 23 (Biological), GARDASIL 9 | Food and Beverage | In-kind items and services | $13.58 | General |
| Category: VACCINE | ||||||
| 02/24/2020 | Arbor Pharmaceuticals, Inc. | Edarbi (Drug) | Food and Beverage | In-kind items and services | $11.39 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 02/17/2020 | Kowa Pharmaceuticals America, Inc. | Livalo (Drug), Bystolic | Food and Beverage | Cash or cash equivalent | $13.19 | General |
| Category: Cardiovascular | ||||||
| 02/04/2020 | PFIZER INC. | COLOGUARD (Device) | Food and Beverage | In-kind items and services | $12.30 | General |
| Category: GASTROINTESTINAL | ||||||
| 01/30/2020 | Boehringer Ingelheim Pharmaceuticals, Inc. | TRADJENTA (Drug), JARDIANCE, GLYXAMBI | Food and Beverage | In-kind items and services | $11.88 | General |
| Category: DIABETES | ||||||
| 01/14/2020 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $17.52 | General |
| Category: Bone Health | ||||||
| 01/07/2020 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $23.95 | General |
| Category: Diabetes | ||||||
| 12/17/2019 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $15.04 | General |
| Category: Bone Health | ||||||
| 12/12/2019 | GlaxoSmithKline, LLC. | SHINGRIX (Biological) | Food and Beverage | In-kind items and services | $15.23 | General |
| Category: VACCINES | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 198 | 204 | $40,925 | $13,195 |
| 2022 | 2 | 183 | 193 | $39,880 | $13,364 |
| 2021 | 9 | 283 | 362 | $62,582 | $22,005 |
| 2020 | 6 | 249 | 355 | $55,012 | $24,989 |
Total Patients
913
Total Services
1,114
Medicare Billing
$73,552
Procedure Codes
20
All Medicare Procedures & Services
20 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 168 | 174 | $34,800 | $11,436 | 32.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 17 | 17 | $4,760 | $1,606 | 33.7% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 13 | 13 | $1,365 | $152.39 | 11.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 167 | 177 | $35,400 | $11,898 | 33.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 16 | 16 | $4,480 | $1,465 | 32.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 80 | 132 | $30,899 | $9,984 | 32.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 50 | 50 | $14,928 | $7,145 | 47.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 31 | 43 | $6,947 | $2,344 | 33.7% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2021 | 13 | 15 | $1,695 | $767.35 | 45.3% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 15 | 20 | $2,400 | $720.39 | 30.0% |
| G0444 | Annual depression screening, 15 minutes | Office | 2021 | 30 | 30 | $1,218 | $609.00 | 50.0% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2021 | 24 | 24 | $2,500 | $283.58 | 11.3% |
| 96127 | Brief emotional or behavioral assessment | Office | 2021 | 11 | 18 | $195.48 | $78.15 | 40.0% |
| 96160 | Administration and interpretation of patient-focused health risk assessment | Office | 2021 | 29 | 30 | $1,800 | $73.50 | 4.1% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 88 | 165 | $27,555 | $13,087 | 47.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 42 | 42 | $12,432 | $5,329 | 42.9% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 38 | 52 | $5,876 | $2,821 | 48.0% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 27 | 31 | $3,490 | $2,020 | 57.9% |
| 99441 | Physician telephone patient service, 5-10 minutes of medical discussion | Office | 2020 | 26 | 37 | $2,775 | $1,414 | 50.9% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2020 | 28 | 28 | $2,884 | $318.21 | 11.0% |
About Dr. Vasu Balu, M.D
Dr. Vasu Balu, M.D is a Internal Medicine healthcare provider based in Westminster, Maryland. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/24/2009. The National Provider Identifier (NPI) number assigned to this provider is 1659504777.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Vasu Balu, M.D has received a total of $4,813 in payments from pharmaceutical and medical device companies, with $136.45 received in 2021. These payments were reported across 312 transactions from 28 companies. The most common payment nature is "Food and Beverage" ($4,808).
As a Medicare-enrolled provider, Balu has provided services to 913 Medicare beneficiaries, totaling 1,114 services with total Medicare billing of $73,552. Data is available for 4 years (2020–2023), covering 20 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Westminster, MD
- Active Since 08/24/2009
- Last Updated 10/07/2024
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1659504777
Products in Payments
- FARXIGA (Drug) $458.71
- Myrbetriq (Drug) $339.98
- JANUVIA (Drug) $261.03
- Tresiba (Drug) $181.35
- Ozempic (Drug) $169.70
- TRULICITY (Drug) $156.56
- TRADJENTA (Drug) $151.73
- BELSOMRA (Drug) $146.08
- TOUJEO (Drug) $144.47
- Trintellix (Drug) $140.62
- JARDIANCE (Drug) $123.04
- Creon (Drug) $122.50
- ENTRESTO (Drug) $121.12
- Aimovig (Biological) $118.93
- ELIQUIS (Drug) $118.36
- ANORO ELLIPTA (Drug) $111.22
- Livalo (Drug) $107.87
- Prolia (Biological) $107.33
- INVOKANA (Drug) $106.82
- BEVESPI AEROSPHERE (Drug) $103.51
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Westminster
Dr. Amit Narula, D.o, D.O
Internal Medicine — Payments: $217,627
Internal Medicine $217,627
Dr. Tung Nguyen, M.d, M.D
Internal Medicine — Payments: $91,770
Internal Medicine $91,770
Dr. Julie Parsons, Md, MD
Internal Medicine — Payments: $32,918
Internal Medicine $32,918
Dr. Dean Ngo, Md, MD
Internal Medicine — Payments: $24,111
Internal Medicine $24,111
Dr. Vuong Nguyen, M.d, M.D
Internal Medicine — Payments: $20,971
Internal Medicine $20,971
Dr. Hieu N Tram, Md, MD
Internal Medicine — Payments: $20,855
Internal Medicine $20,855